Skip to main content
Top
Published in: Current Oncology Reports 2/2011

01-04-2011

Changing the Perspective: Current Trends in the Assessment of Functional Outcome in Patients with Head and Neck Cancer

Author: Uta Tschiesner

Published in: Current Oncology Reports | Issue 2/2011

Login to get access

Abstract

Functional outcome and quality of life have become frequent outcome measures in head and neck cancer (HNC) clinical trials. Many thoroughly validated outcome measures are available. Still, there is a low degree of standardization and comparability among measures. It seems difficult to fully translate the new insights into clinical routine. The aims of this paper are 1) to acknowledge the diversity of outcome measures and many of the past milestones that have been reached, but also 2) to capture a growing need to concentrate and reach consensus. The hypothesis is to gain more benefit from changing the perspective toward consensus rather than diversity in functional outcome assessment. The next steps are to adopt a unique “language” to describe functional outcome and implement clear end points that assist clinical decision making. The International Classification of Functioning, Disability, and Health was adopted by the WHO and offers an internationally accepted classification to describe disability in HNC.
Literature
1.
go back to reference National Comprehensive Cancer Network I. Practise guidelines on head and neck cancer. 2010. National Comprehensive Cancer Network I. Practise guidelines on head and neck cancer. 2010.
2.
go back to reference Byers R. Neck dissection: concepts, controversies, and techniques. Semin Surg Oncol. 1991;7:9–13.PubMedCrossRef Byers R. Neck dissection: concepts, controversies, and techniques. Semin Surg Oncol. 1991;7:9–13.PubMedCrossRef
3.
go back to reference Karatzanis A, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis G, et al. Evaluation of available surgical management options for early supraglottic cancer. Head Neck. 2010;32(8):1048–55.PubMedCrossRef Karatzanis A, Psychogios G, Zenk J, Waldfahrer F, Hornung J, Velegrakis G, et al. Evaluation of available surgical management options for early supraglottic cancer. Head Neck. 2010;32(8):1048–55.PubMedCrossRef
4.
go back to reference Bozec A, Poissonnet G, Chamorey E, Casanova C, Laout C, Vallicioni J. Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg. 2009;38(3):401–8.PubMed Bozec A, Poissonnet G, Chamorey E, Casanova C, Laout C, Vallicioni J. Quality of life after oral and oropharyngeal reconstruction with a radial forearm free flap: prospective study. J Otolaryngol Head Neck Surg. 2009;38(3):401–8.PubMed
5.
go back to reference Sharp D, Theile D, Cook R, Coman W. Long-term functional speech and swallowing outcomes following pharyngolaryngectomy with free jejunal flap reconstruction. Ann Plast Surg. 2010;64(6):743–6.PubMedCrossRef Sharp D, Theile D, Cook R, Coman W. Long-term functional speech and swallowing outcomes following pharyngolaryngectomy with free jejunal flap reconstruction. Ann Plast Surg. 2010;64(6):743–6.PubMedCrossRef
6.
go back to reference Mittal B, Kepka A, Mahadevan A, Kies M, Pelzer H, List M, et al. Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers. Int J Cancer. 2001;96(Suppl):61–70.PubMedCrossRef Mittal B, Kepka A, Mahadevan A, Kies M, Pelzer H, List M, et al. Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers. Int J Cancer. 2001;96(Suppl):61–70.PubMedCrossRef
7.
go back to reference Eisbruch A, Dawson L, Kim H, Bradford C, Terrell J, Chepeha D, et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg. 1999;53(3):271–5.PubMed Eisbruch A, Dawson L, Kim H, Bradford C, Terrell J, Chepeha D, et al. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg. 1999;53(3):271–5.PubMed
8.
go back to reference Colosanto J, Prasad P, Nash M, et al. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology. 2005;19:371–82. Colosanto J, Prasad P, Nash M, et al. Nutritional support of patients undergoing radiation therapy for head and neck cancer. Oncology. 2005;19:371–82.
9.
go back to reference Yueh B. Measuring and reporting quality of life in head and neck cancer. Cancer. 2002. Yueh B. Measuring and reporting quality of life in head and neck cancer. Cancer. 2002.
10.
go back to reference •Mapi Reserach Institute. ProQuolid: Patient reported outcome and quality of life instruments database. 2010. http://www.proqolid.org/. This gives an excellent overview of available questionnaires and their properties. •Mapi Reserach Institute. ProQuolid: Patient reported outcome and quality of life instruments database. 2010. http://​www.​proqolid.​org/​. This gives an excellent overview of available questionnaires and their properties.
11.
go back to reference Bjordal K, de Graeff A, Fayers P, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36(14):1796–807.PubMedCrossRef Bjordal K, de Graeff A, Fayers P, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36(14):1796–807.PubMedCrossRef
12.
go back to reference Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9.PubMed
13.
go back to reference Campbell BH, Marbella A, Layde PM. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope. 2000;110(6):895–906.PubMedCrossRef Campbell BH, Marbella A, Layde PM. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope. 2000;110(6):895–906.PubMedCrossRef
14.
go back to reference Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller Jr EA. The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck. 2002;24(6):521–9.PubMedCrossRef Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller Jr EA. The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck. 2002;24(6):521–9.PubMedCrossRef
15.
go back to reference Terrell JE, Fisher SG, Wolf GT. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg. 1998;124(9):964–71.PubMed Terrell JE, Fisher SG, Wolf GT. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg. 1998;124(9):964–71.PubMed
16.
go back to reference Trotti A, Johnson DJ, Gwede C, Casey L, Sauder B, Cantor A, et al. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). Int J Radiat Oncol Biol Phys. 1998;42(2):257–61.PubMedCrossRef Trotti A, Johnson DJ, Gwede C, Casey L, Sauder B, Cantor A, et al. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). Int J Radiat Oncol Biol Phys. 1998;42(2):257–61.PubMedCrossRef
17.
go back to reference Funk G, Karnell L, Christensen A, Moran P, Ricks J. Comprehensive head and neck oncology health status assessment. Head Neck. 2003;25(7):561–75.PubMedCrossRef Funk G, Karnell L, Christensen A, Moran P, Ricks J. Comprehensive head and neck oncology health status assessment. Head Neck. 2003;25(7):561–75.PubMedCrossRef
18.
go back to reference Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, et al. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003;26(6):1093–104.PubMedCrossRef Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, et al. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003;26(6):1093–104.PubMedCrossRef
19.
go back to reference Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A. Content comparison of quality of life questionnaires used in Head and Neck Cancer based on the International Classification of Functioning, Disability and Health (ICF): a systematic review. Eur Arch Otorhinolaryngol. 2008;265(6):627–37.PubMedCrossRef Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A. Content comparison of quality of life questionnaires used in Head and Neck Cancer based on the International Classification of Functioning, Disability and Health (ICF): a systematic review. Eur Arch Otorhinolaryngol. 2008;265(6):627–37.PubMedCrossRef
20.
go back to reference List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer. 1996;77(11):2294–301.PubMedCrossRef List MA, D’Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer. 1996;77(11):2294–301.PubMedCrossRef
21.
go back to reference Pauloski B, Rademaker A, Lazarus C, Boeckxstaens G, Kahrilas P, Logemann J. Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities. Dysphagia. 2009;24(2):196–203.PubMedCrossRef Pauloski B, Rademaker A, Lazarus C, Boeckxstaens G, Kahrilas P, Logemann J. Relationship between manometric and videofluoroscopic measures of swallow function in healthy adults and patients treated for head and neck cancer with various modalities. Dysphagia. 2009;24(2):196–203.PubMedCrossRef
22.
go back to reference Singh A, Kazi R, De Cordova J, Nutting CM, Clarke P, Harrington KJ, et al. Multidimensional assessment of voice after vertical partial laryngectomy: a comparison with normal and total laryngectomy voice. J Voice. 2008;22(6):740–5.PubMedCrossRef Singh A, Kazi R, De Cordova J, Nutting CM, Clarke P, Harrington KJ, et al. Multidimensional assessment of voice after vertical partial laryngectomy: a comparison with normal and total laryngectomy voice. J Voice. 2008;22(6):740–5.PubMedCrossRef
23.
go back to reference Mehanna H, Morton R. Why are head and neck cancer clinicians not measuring quality of life? J Laryngol Otol. 2006;120(10):861–4.PubMedCrossRef Mehanna H, Morton R. Why are head and neck cancer clinicians not measuring quality of life? J Laryngol Otol. 2006;120(10):861–4.PubMedCrossRef
24.
go back to reference Pace-Balzan A, Butterworth C, Dawson L, Lowe D, Rogers S. A survey of consultants and specialists in restorative dentistry on their use of health-related quality of life questionnaires. Eur J Prosthodont Restor Dent. 2007;15(3):122–6.PubMed Pace-Balzan A, Butterworth C, Dawson L, Lowe D, Rogers S. A survey of consultants and specialists in restorative dentistry on their use of health-related quality of life questionnaires. Eur J Prosthodont Restor Dent. 2007;15(3):122–6.PubMed
25.
go back to reference Mehanna H, Morton R. Patients’ views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial. Clin Otolaryngol. 2006;31(4):310–6.PubMedCrossRef Mehanna H, Morton R. Patients’ views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial. Clin Otolaryngol. 2006;31(4):310–6.PubMedCrossRef
26.
go back to reference Funk GF, Karnell LH, Smith RB, Christensen AJ. Clinical significance of health status assessment measures in head and neck cancer: what do quality-of-life scores mean? Arch Otolaryngol Head Neck Surg. 2004;130(7):825–9.PubMedCrossRef Funk GF, Karnell LH, Smith RB, Christensen AJ. Clinical significance of health status assessment measures in head and neck cancer: what do quality-of-life scores mean? Arch Otolaryngol Head Neck Surg. 2004;130(7):825–9.PubMedCrossRef
27.
go back to reference Ringash J, O’Sullivan B, Bezjak A, Redelmaier D. Interpreting clinically significant changes in patient-reported outcomes. Cancer. 2007;110(1):196–202.PubMedCrossRef Ringash J, O’Sullivan B, Bezjak A, Redelmaier D. Interpreting clinically significant changes in patient-reported outcomes. Cancer. 2007;110(1):196–202.PubMedCrossRef
28.
go back to reference Frowen J, Perry A. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck. 2006;28(10):932–44.PubMedCrossRef Frowen J, Perry A. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck. 2006;28(10):932–44.PubMedCrossRef
29.
go back to reference Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A. Comparison of outcome measures in head and neck cancer- a literature review 2000–2006. Head Neck. 2009;31(2):251–9.PubMedCrossRef Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A. Comparison of outcome measures in head and neck cancer- a literature review 2000–2006. Head Neck. 2009;31(2):251–9.PubMedCrossRef
30.
go back to reference Trotti A, Colevas D, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25(32):5121–7.PubMedCrossRef Trotti A, Colevas D, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25(32):5121–7.PubMedCrossRef
31.
go back to reference Trotti A, Pajak T, Gwede C, Paulus R, Cooper J, Forastiere A, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 2007;8(7):613–24.PubMedCrossRef Trotti A, Pajak T, Gwede C, Paulus R, Cooper J, Forastiere A, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol. 2007;8(7):613–24.PubMedCrossRef
32.
go back to reference •World Health Organization. ICF—International Classification of Functioning, Disability and Health. available: http://wwwwhoint/classifications/icf/en/. 2001;Geneva. This provides ICF classification in different languages and gives detailed information on its theoretical background, ICF applications, and present projects. •World Health Organization. ICF—International Classification of Functioning, Disability and Health. available: http://​wwwwhoint/​classifications/​icf/​en/​. 2001;Geneva. This provides ICF classification in different languages and gives detailed information on its theoretical background, ICF applications, and present projects.
33.
go back to reference World Health Organization. Rehabilitation, with special emphasis on developing countries. Report of WHO expert committee. Geneva; 1993. World Health Organization. Rehabilitation, with special emphasis on developing countries. Report of WHO expert committee. Geneva; 1993.
34.
go back to reference Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Üstün TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil. 2002;24:281–2.PubMedCrossRef Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Üstün TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil. 2002;24:281–2.PubMedCrossRef
35.
go back to reference Stucki G, Grimby G. Applying the ICF in medicine. J Rehabil Med. 2004;Jul;(44 Suppl):5–6. Stucki G, Grimby G. Applying the ICF in medicine. J Rehabil Med. 2004;Jul;(44 Suppl):5–6.
36.
go back to reference Brach M, Cieza A, Stucki G, Fussl M, Cole A, Ellerin B, et al. ICF Core Sets for breast cancer. J Rehabil Med. 2004 Jul(44 Suppl):121–7. Brach M, Cieza A, Stucki G, Fussl M, Cole A, Ellerin B, et al. ICF Core Sets for breast cancer. J Rehabil Med. 2004 Jul(44 Suppl):121–7.
37.
go back to reference Tschiesner U, Rogers SN, Dietz A, Yueh B, Cieza A. Development of ICF Core Sets for head and neck cancer. Head Neck. 2010;32(2):210–20.PubMed Tschiesner U, Rogers SN, Dietz A, Yueh B, Cieza A. Development of ICF Core Sets for head and neck cancer. Head Neck. 2010;32(2):210–20.PubMed
38.
go back to reference Tschiesner U, Linseisen E, Becker S, Mast G, Rogers SN, Walvekar RR, Berghaus A, Cieza A. Validation of the international classification of functioning, disability and health core sets for head and neck cancer: a multicentre study. J Otolaryngol Head Neck Surg. 2010 Dec 39(6):674–87. Tschiesner U, Linseisen E, Becker S, Mast G, Rogers SN, Walvekar RR, Berghaus A, Cieza A. Validation of the international classification of functioning, disability and health core sets for head and neck cancer: a multicentre study. J Otolaryngol Head Neck Surg. 2010 Dec 39(6):674–87.
39.
go back to reference Tschiesner U, Linseisen E, Coenen M, Rogers S, Harreus U, Berghaus A, et al. Evaluating sequelae after head and neck cancer from the patient perspective with the help of the International Classification of Functioning, Disability and Health. Eur Arch Otorhinolaryngol. 2009;266(3):425–36.PubMedCrossRef Tschiesner U, Linseisen E, Coenen M, Rogers S, Harreus U, Berghaus A, et al. Evaluating sequelae after head and neck cancer from the patient perspective with the help of the International Classification of Functioning, Disability and Health. Eur Arch Otorhinolaryngol. 2009;266(3):425–36.PubMedCrossRef
40.
go back to reference Tschiesner U, Becker S, Cieza A. Health professional perspective on disability in head and neck cancer. Otolaryngol Head Neck Surg. 2010;136(6):576–83.CrossRef Tschiesner U, Becker S, Cieza A. Health professional perspective on disability in head and neck cancer. Otolaryngol Head Neck Surg. 2010;136(6):576–83.CrossRef
41.
go back to reference Tschiesner U, Linseisen E, Baumann S, Siedek V, Stelter K, Berghaus A, et al. Assessment of functioning in patients with head and neck cancer according to the International classification of Functioning, Disability and Health (ICF)—a multi-centre study. Laryngoscope. 2009;119(5):915–23.PubMedCrossRef Tschiesner U, Linseisen E, Baumann S, Siedek V, Stelter K, Berghaus A, et al. Assessment of functioning in patients with head and neck cancer according to the International classification of Functioning, Disability and Health (ICF)—a multi-centre study. Laryngoscope. 2009;119(5):915–23.PubMedCrossRef
42.
go back to reference Rogers SN, Forgie S, Lowe D, Precious L, Haran S, Tschiesner U. Development of the brief ICF core set for head and neck cancer as a patient self-completed questionnaire. Int J Oral Maxillofac Surg. 2010;39(10):975–82.PubMedCrossRef Rogers SN, Forgie S, Lowe D, Precious L, Haran S, Tschiesner U. Development of the brief ICF core set for head and neck cancer as a patient self-completed questionnaire. Int J Oral Maxillofac Surg. 2010;39(10):975–82.PubMedCrossRef
43.
go back to reference Becker S, Kirchberger I, Cieza A, Berghaus A, Harreus U, Tschiesner U. Content validation of the comprehensive ICF core set for head and neck cancer: the perspective of psychologists. Psychooncol. 2009;19(6):594–605.CrossRef Becker S, Kirchberger I, Cieza A, Berghaus A, Harreus U, Tschiesner U. Content validation of the comprehensive ICF core set for head and neck cancer: the perspective of psychologists. Psychooncol. 2009;19(6):594–605.CrossRef
44.
go back to reference Kostanjsek N, Rubinelli S, Escorpizio R, Cieza A, Kennedy C, Stucki G, et al. Assessing the impact of health conditions using the ICF. Disability and Rehabilitation. 2010 (in press). Kostanjsek N, Rubinelli S, Escorpizio R, Cieza A, Kennedy C, Stucki G, et al. Assessing the impact of health conditions using the ICF. Disability and Rehabilitation. 2010 (in press).
Metadata
Title
Changing the Perspective: Current Trends in the Assessment of Functional Outcome in Patients with Head and Neck Cancer
Author
Uta Tschiesner
Publication date
01-04-2011
Publisher
Current Science Inc.
Published in
Current Oncology Reports / Issue 2/2011
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-011-0156-1

Other articles of this Issue 2/2011

Current Oncology Reports 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine